The shMFE23 diabody targeting the carcinoembryonic antigen (CEA) was used as control; pre-treatment with this diabody had no effect on the CEA-positive Capan-1 cells or the melanoma cell lines, negative for CEA [17]. The gene discussed is CEACAM5; the disease is melanoma.